News
Events
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact
Events
Read our news
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact us
Genzyme Begins Enrolling Patients in Pompe Disease Study
For Immediate Release March 19, 2003 Media Contact: Bo Piela 617-252-7785 Investor Contact: Sally Curley 617-591-7140 CAMBRIDGE, Mass...
Author:
Genzyme
Archive
March 18, 2003
Pompe Program Update
Genzyme continues to make good progress within its program to develop a treatment for Pompe disease. Since our...
Author:
Genzyme
Archive
February 17, 2003
Pompe Program Update
Genzyme’s Pompe Program Update Q&A, December 2002 This Question and Answer session is derived from December’s IPA/Genzyme teleconference...
Author:
Genzyme
Archive
December 16, 2002
Summary of IPA/Genzyme Teleconference from September 24, 2002
Baarn, October 2nd 2002 Dear IPA members, Herewith I would like to inform you about the IPA/Genzyme telephone...
Author:
IPA
Archive
September 23, 2002
Joint Statement following April 2002 Meeting
On 16/17 April, 2002 Board members of the IPA, the International Pompe Association, met with key representatives of...
Author:
IPA/Genzyme
Archive
April 16, 2002
Genzyme and Pharming Reach Agreement on Remaining Issues
CAMBRIDGE, Mass. and LEIDEN, the Netherlands-Genzyme Corp. and Pharming Group N.V. (Euronext: PHAR / Nasdaq Europe: PHAR) announced...
Author:
Genzyme
Archive
December 9, 2001
Genzyme Acquires Pharming’s Production Plant in Geel, Belgium
CAMBRIDGE, Mass.-Genzyme Corp. announced today that it has acquired certain assets of Pharming N.V., the Belgian subsidiary of...
Author:
Genzyme
Archive
October 29, 2001
Genyzyme General Reports 33 Percent Increase In Third-Quarter Revenues
Genzyme quarterly report shows $17.2 million set aside to ensure continued supply of transgenic alpha glucosidase. [NB- this...
Author:
Genzyme
Archive
October 17, 2001
Genzyme Completes Deal to Acquire Novazyme
Genzyme Completes Acquisition of Novazyme Pharmaceuticals Genzyme Corp. announced September 27 that it has completed the acquisition of...
Author:
Genzyme
Archive
September 26, 2001
Genzyme to Acquire Certain Assets of Pharming
CAMBRIDGE, Mass. — Genzyme Corporation announced today that it has signed a conditional agreement to acquire certain assets...
Author:
Genzyme
Archive
September 18, 2001
1
…
35
36
37
38